Immunocore Holdings plc (FRA:6YG)
Germany · Delayed Price · Currency is EUR 24.60
-0.20 (-0.81%)
Last updated: Apr 24, 2026, 8:10 AM CET
Immunocore Holdings Market Cap
Immunocore Holdings has a market cap or net worth of €1.27 billion as of April 24, 2026. Its market cap has increased by 12.65% in one year.
Market Cap
1.27B
Enterprise Value
903.50M
Revenue
340.69M
Ranking
n/a
PE Ratio
n/a
Stock Price
€24.60
Market Cap Chart
Since February 5, 2021, Immunocore Holdings's market cap has decreased from 1.49B to 1.27B, a decrease of -15.04%. That is a compound annual growth rate of -3.08%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 23, 2026 | 1.27B | -15.09% |
| Dec 31, 2025 | 1.49B | 4.78% |
| Dec 31, 2024 | 1.43B | -53.35% |
| Dec 29, 2023 | 3.06B | 19.45% |
| Dec 30, 2022 | 2.56B | 93.80% |
| Dec 31, 2021 | 1.32B | -11.59% |
| Feb 5, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Biotest Aktiengesellschaft | 1.45B |
| Darwin AG | 92.40M |
| 2invest AG | 49.36M |
| Biomark Diagnostics | 35.52M |
| co.don AG | 374.13K |
| Paion AG | 278.21K |
| bioXXmed AG | 244.68K |
| MagForce AG | 122.29K |